Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp Investor Day Transcript

Sep 22, 2021 / 12:30PM GMT
Release Date Price: €36.88 (-0.86%)
Operator

Please welcome to the stage the Vice President of Investor Relations, Lauren Tengler.

Lauren Tengler
Boston Scientific Corporation - Director of IR

Thank you. Welcome, everyone, both here in the room and virtually online. On behalf of Boston Scientific, we want to thank you for joining us today. I hope you enjoyed that video as much as I did. It really highlights how Boston Scientific puts the patient first through the relentless pursuit of innovation. And you're going to hear more about that today. But first, we have some disclaimers to go through.

So we will be making forward-looking statements. So typical safe harbor and risk factors apply. Please refer to our latest SEC filings, 10-Qs and 10-Ks for more information.

Next we're going to be talking about a lot of different products today, some of which are not available globally. So please refer to this slide for more information.

And finally, we have some financial disclaimers. Please note the use of organic and other non-GAAP measures denoted throughout the presentation. Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot